Korsana Biosciences Inc. – Filings and Transcripts

NASDAQ: KRSA
Share price (11/6/26): $31.05
Market cap (11/6/26): $1.414 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/26 Q3

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

Prospectuses and Registrations Filter

Business combination disclosure

Business combination disclosure

Business combination disclosure

Business combination disclosure

Business combination disclosure

Ownership Filter

Higgins Michael J

J. Wood Capital Advisors LLC

Desouza Errol B

Desouza Errol B

News Filter

Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Completes Closing of Merger With Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million

Shareholder Vote Results, Other Events, Financial Statements or Exhibits

Cyclerion Therapeutics and Korsana Biosciences Announce Merger Agreement

Proxies Filter

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness